Coagulation indices and fibrinogen degradation products as predictive biomarkers for tumor-node-metastasis staging and metastasis in gastric cancer

doi:10.4251/wjgo.v17.i1.98725

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (226)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

HTML

113

Figures (1-4)

Tables (1-3)

Sum=175

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=46

Jan 15, 2025 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jan 15, 2025; 17(1): 98725
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.98725

Open in New Tab Full Size Figure Download Figure

Figure 1 Comparison of tumor node metastasis staging and coagulation function. A: Comparison of activated partial thromboplastin times in patients with different tumor node metastasis (TNM) stages; B: Comparison of Antithrombin-III in patients with different TNM stages; C: Comparison of thrombin times in patients with different TNM stages; D: Comparison of prothrombin time in patients with different TNM stages. APTT: Activated partial thromboplastin time; AT-III: Antithrombin III; TT: Thrombin time; PT: Prothrombin time; TNM: Tumor node metastasis.

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of tumor node metastasis staging and fibrinogen degradation products. A: A comparison of D-Dimer in patients with different tumor node metastasis (TNM) stages; B: Comparison of fibrinogen in patients with different TNM stages; C: Comparison of fibrinogen degradation products in patients with different TNM stages. D-D: D-Dimer; FBG: Fibrinogen; FDP: Fibrinogen degradation product; TNM: Tumor node metastasis.

Open in New Tab Full Size Figure Download Figure

Figure 3 Comparison of distant metastasis and coagulation function. A: Comparison of activated partial thromboplastin time times in patients with or without distant metastasis; B: Comparison of antithrombin-III in patients with or without distant metastasis; C: Comparison of thrombin time times in patients with or without distant metastasis; D: Comparison of prothrombin time times in patients with or without distant metastasis. APTT: Activated partial thromboplastin time; AT-III: Antithrombin III; TT: Thrombin time; PT: Prothrombin time; TNM: Tumor node metastasis.

Open in New Tab Full Size Figure Download Figure

Figure 4 Comparison of distant metastasis and fibrinogen degradation products. A: Comparison of D-Dimer in patients with or without distant metastasis; B: Comparison of fibrinogen in patients with or without distant metastasis; C: Comparison of fibrinogen degradation product times in patients with or without distant metastasis. D-D: D-Dimer; FBG: Fibrinogen; FDP: Fibrinogen degradation product; TNM: Tumor node metastasis.

Citation: Shen YQ, Wei QW, Tian YR, Ling YZ, Zhang M. Coagulation indices and fibrinogen degradation products as predictive biomarkers for tumor-node-metastasis staging and metastasis in gastric cancer. World J Gastrointest Oncol 2025; 17(1): 98725
URL: https://www.wjgnet.com/1948-5204/full/v17/i1/98725.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.98725